BrightSpec, Inc.

About

BrightSpec, Inc. is a life sciences tools company that specializes in molecular analysis and characterization through its innovative molecular rotational resonance (MRR) spectroscopy instruments. Founded in 2012 and based in Charlottesville, Virginia, BrightSpec emerged from an NSF Innovation Corps initiative, focusing on commercializing MRR technology. The company's primary product is the spectraMRR™ platform, which has received recognition, including the 2025 R&D 100 Award in the Analytical/Test category. BrightSpec also offers the nanoMRR instrument for educational and research purposes. Their technology features advanced capabilities such as quantum simulation for predicting molecular spectra, ultra-high resolution for precise identification of gas-phase molecules, and rapid analysis that provides results within minutes. BrightSpec serves various markets, including pharmaceuticals, chemicals, and consumer goods, offering analytical instruments and lab services for molecular identification and quantitative analysis. The company has successfully raised $24.35 million in funding, with a recent Series C round contributing $18.4 million in 2022.